Series C financing led by NEA Provides advancement of INV-202 Phase 2 clinical trial in Diabetic Kidney Disease in Q4 Inversago Pharma Inc. ("Inversago"), a clinical stage biotech company with a unique
Partnership extended via new private financing
CHICAGO and NEW YORK, Oct. 11, 2022 /PRNewswire/ G Squared Ascend I Inc. , a publicly traded special purpose acquisition company sponsored by. | October 11, 2022
/PRNewswire/ New Enterprise Associates, Inc. (NEA) announced today that Philip Chopin, a seasoned technology investor who most recently served as a partner.